Connect with us

News

Terminally ill groom dies at altar as bride walks down aisle

Published

on

A groom with terminal cancer died at the altar as his bride was walking down the aisle to meet him, according to a report.

Paul Wynn, a 57-year-old dad of 11, was sitting in a chair waiting for his beloved partner of 21 years, Alison Wynn, to greet him at their nuptials in a town hall in Scotland, the Sun said.

Paul Wynn (far right)

A Scotsman with terminal cancer collapsed and died at the altar last Friday as his horrified bride and their son walked down the aisle, according to a report.

Paul Wynn, 57, a father-of-eleven, passed just minutes before he was due to marry his partner of 21 years, Alison Wynn.

Doctors told the groom he had cancer in May but only diagnosed it as terminal a little more than a week ago, according to the Daily Mail.
Doctors had told groom Paul Wynn, right, he had cancer in May but only diagnosed it as terminal a little more than a week ago.
Family photo

Before the ceremony, Wynn said, “Everything seemed to be OK, although Paul seemed to be a bit uncomfortable by this point, and his kilt had been loosened a wee bit to help him feel more comfortable.”

“By the time I got to him, I called his name a couple of times,” she said. “He didn’t turn round, he didn’t look at me, and I realized there was something wrong, and I started breaking down, and I started shouting his name, and we knew something wasn’t right.”

Doctors had told the groom he had cancer in May but only diagnosed it as terminal a little more than a week ago, according to the Sun.

Alison Wynn on her wedding day.
Alison Wynn had five children with Paul.
Family photo

Wynn and his beau rushed to tie the knot before he passed away, and they managed to hastily organize a wedding in the town of Saltcoats.

Doctors had told Wynn that he had up to two months to live.

First-responders were unable to revive him at the wedding.

“I’m having to get up and moving every day for the sake of my children, but I can’t eat,” said the heartbroken bride, who has five children with Wynn.

“Paul and I lost a child in 2004 after I had a miscarriage, so it gives me a bit of comfort that he’s up there with our child,” Alison said. “His mother passed away in 2020, so at least he’s with her now, too.

“We were his life, he would do anything for his kids,” his bride said, adding that her partner had been a freelance photographer. “He would move heaven and Earth for his kids, and everyone loved him.”

News

Biden on Omicron: We're going to fight and beat this variant – CNN

Published

on

Biden on Omicron: We’re going to fight and beat this variant  CNN

Continue Reading

News

CDC tells adults to get booster shot amid omicron concerns

Published

on

Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky gives her opening statement during the Senate Health, Education, Labor and Pensions hearing on “Next Steps: The Road Ahead for the COVID-19 Response” on Capitol Hill in Washington, November 4, 2021.

Elizabeth Frantz | Reuters

The Centers for Disease Control and Prevention on Monday strengthened its recommendation on Covid booster shots, telling all adults that they “should” get an additional dose amid growing concern about the newly identified omicron variant.

“The recent emergence of the Omicron variant (B.1.1.529) further emphasizes the importance of vaccination, boosters, and prevention efforts needed to protect against COVID-19,” CDC Director Dr. Rochelle Walensky said in a statement Monday.

The CDC cleared booster doses for all adults earlier this month, saying everyone over 18 “may” get a shot if they wanted one. Only people 50 and over were told they “should” get the shots at the time. The agency is now giving its strongest recommendation for everyone 18 and older, saying they should get an additional shot six months after their initial Pfizer or Moderna series, or two months after their first Johnson & Johnson shot.

The World Health Organization, in a paper published Sunday, warned that global risk posed by omicron is “very high.” The variant has more than 30 mutations on its spike protein alone, some of which are associated with higher transmission and reduced antibody protection. The WHO said these mutations could fuel future surges of infection with “severe consequences.”

“Early data from South Africa suggest increased transmissibility of the Omicron variant, and scientists in the United States and around the world are urgently examining vaccine effectiveness related to this variant,” Walensky said.

Though omicron is believed to be more infectious than the predominant delta variant, it is not yet clear how much the heavily mutated strain will affect the strength of currently available vaccines. Moderna and Pfizer said they will have more data on this in about two weeks. The companies maintain that they can adjust their vaccines relatively quickly to combat new variants.

“I don’t think that the result will be the vaccines don’t protect,” Pfizer CEO Albert Bourla told CNBC’s “Squawk Box” on Monday. “I think the result could be, which we don’t know yet, the vaccines protect less.”

Bourla said that Pfizer can develop a new vaccine within 100 days. Moderna CEO Stephane Bancel told CNBC on Monday that the company could deploy a higher-dosage booster shot against omicron quickly but a variant-specific vaccine could take months.

Though omicron has not yet been detected in the U.S., President Joe Biden on Monday said the country will face the variant sooner or later, and encouraged Americans to get booster shots for added protection. Walensky, in her Monday statement, urged people to get tested as well.

“I also want to encourage people to get a COVID-19 test if they are sick,” Walensky said. “Increased testing will help us identify Omicron quickly.”

The emergence of omicron comes as public health officials are already concerned about a winter Covid surge and declining vaccine strength.

A study published in the journal Science this month found that the Pfizer vaccine’s efficacy at preventing infection declined from 86% to 43% from February to October. Moderna’s vaccine dropped from 89% to 58%, and J&J’s vaccine fell from 86% to 13% efficacy against infection in the same study.

However, Pfizer found that its booster dose provides 95% protection against symptomatic infection in a clinical trial of 10,000 people.

Continue Reading

News

New Blood Video Shows Michael C. Hall & Cast Answering Dexter Trivia – Screen Rant

Published

on

New Blood Video Shows Michael C. Hall & Cast Answering Dexter Trivia  Screen Rant

Continue Reading

Trending